Director's Dealings

RNS Number : 2683C

Futura Medical PLC

15 January 2015

 



For Immediate Release

15 January 2015

Futura Medical plc

("Futura" or the "Company")

Director's Dealings

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that it has today received notification from James Barder, the Chief Executive of the Company, that he and his wife have gifted in aggregate 50,000 ordinary shares in the Company to a shareholding account jointly held by their children.

Following the transfer, Mr. Barder's revised aggregate beneficial and non-beneficial holding is 958,830 ordinary shares, representing 0.97 per cent. of the Company's issued share capital.

For further information please contact:                           For media enquiries please contact:

Futura Medical plc                                                              Buchanan Communications Limited
James Barder, Chief Executive                                            Mark Court / Sophie Cowles + 44 (0) 1483 685 670                                                          + 44 (0) 20 7466 5000 [e-mail]                                       www.futuramedical.com
Nominated Adviser N+1 Singer Aubrey Powell [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

RDSMMGMMZKZGKZM